Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Delcath Systems Inc (DCTH)  
$12.00 0.98 (7.55%) as of 4:30 Thu 4/3


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 15,280,000
Market Cap: 183.36(M)
Last Volume: 1,505,916 Avg Vol: 1,493,213
52 Week Range: $4.695 - $16.45
Level I Sector: Industrials
Level II Sector: Diversified Services
Level III Sector: Research Services

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Co.'s primary product candidate, the HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system) (HEPZATO), is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In Europe, Co.'s commercial product is a stand-alone medical device having the same device components as the HEZPATO but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT® Hepatic Delivery System for Melphalan.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 382,819
Total Buy Value $0 $0 $0 $1,081,809
Total People Bought 0 0 0 8
Total Buy Transactions 0 0 0 10
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-01-02 2024-10-01 2024-04-02 2023-04-03

   
Records found: 124
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Salamon Steven A J Director   –       •      –    2024-12-24 4 OE $10.00 $2,500,000 I/I 250,000 3,013,468     -
   Aharon Gil Director   –       •      –    2024-12-24 4 OE $10.00 $2,500,000 I/I 250,000 3,013,468     -
   Michel Gerard J CHIEF EXECUTIVE OFFICER   •       •      –    2024-10-22 4 OE $6.00 $99,996 D/D 16,666 319,334     -
   Aharon Gil Director   –       •      –    2024-04-18 4 A $0.00 $0 I/I 991,615 2,681,271     -
   Aharon Gil Director   –       •      –    2024-04-18 4 OE $6,199.46 $2,147,483,647 I/I 619,946 2,681,271     -
   Aharon Gil Director   –       •      –    2024-04-18 4 A $0.00 $0 I/I 991,615 2,763,468     -
   Aharon Gil Director   –       •      –    2024-04-18 4 OE $6,199.46 $2,147,483,647 I/I 619,946 2,763,468     -
   Aharon Gil Director   –       •      –    2024-04-18 4/A A $0.00 $0 I/I 991,615 2,681,271     -
   Aharon Gil Director   –       •      –    2024-04-18 4/A OE $0.01 $6,199 I/I 619,946 2,681,271     -
   Salamon Steven A J Director   –       •      –    2024-04-18 4 OE $6,199.46 $2,147,483,647 I/I 619,946 2,732,586     -
   Salamon Steven A J Director   –       •      –    2024-04-18 4 A $0.00 $0 I/I 991,615 2,732,586     -
   Salamon Steven A J Director   –       •      –    2024-04-18 4/A A $0.00 $0 I/I 991,615 2,732,586     -
   Salamon Steven A J Director   –       •      –    2024-04-18 4/A OE $0.01 $6,199 I/I 619,946 2,732,586     -
   Salamon Steven A J Director   –       •      –    2024-03-19 4 B $3.72 $100,001 D/D 26,882 1,121,025 2.39 98%     
   Aharon Gil Director   –       •      –    2024-03-19 4 B $3.72 $100,001 D/D 26,882 1,069,710 2.39 98%     
   Hoffman David L. GENL COUNSEL, CCO & SECY   •       –      –    2024-03-19 4 A $3.72 $74,999 D/D 20,161 74,330     -
   Pennell Sandra SVP OF FINANCE, PFO AND PAO   •       –      –    2024-03-19 4 A $3.72 $99,997 D/D 26,881 61,052     -
   Muir Kevin GM INTERVENTIONAL ONCOLOGY   •       –      –    2024-03-19 4 A $3.72 $50,001 D/D 13,441 18,582     -
   Vukovic Vojo CHIEF MEDICAL OFFICER   •       –      –    2024-03-19 4 A $3.72 $100,001 D/D 26,882 126,882     -
   Michel Gerard J CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-19 4 A $3.72 $150,002 D/D 40,323 302,668     -
   Vukovic Vojo Chief Medical Officer   •       –      –    2023-12-12 4 B $3.00 $120,000 D/D 40,000 100,000 2.74 74%     
   Michel Gerard J Chief Executive Officer   •       •      –    2023-12-08 4 B $2.94 $99,960 D/D 34,000 262,345 2.81 85%     
   Aharon Gil Director   –       •      –    2023-11-17 4 B $2.40 $240,410 I/I 100,000 1,038,828 2.1 96%     
   Pennell Sandra SVP of Finance, PFO and PAO   •       –      –    2023-11-17 4 B $2.43 $72,900 D/D 30,000 30,000 2.74 96%     
   Vukovic Vojo Chief Medical Officer   •       –      –    2023-11-16 4 B $2.48 $148,800 D/D 60,000 60,000 2.74 93%     
  124 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us